Naseem Zojwalla - 25 Jan 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 25 Jan 2024
Net transactions value: +$140,400
Form type: 4
Filing time: 29 Jan 2024, 07:30:07 UTC
Previous filing: 12 Dec 2023
Next filing: 05 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$140,400	+20,000	+43%	$7.02	66,664	25 Jan 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-20,000	-8.5%	$0.000000	214,000	25 Jan 2024	Common Stock	20,000	$7.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.